In an exclusive interview with Thiruamuthan, Assistant Editor at India Pharma Outlook, Amit Chopra, CEO – South Asia and Middle East, Cotecna Group, discusses how FDA and EMA have intensified nitrosamine scrutiny, and explains why it has become

In an interaction with Thiruamuthan, Assistant Editor of India Pharma Outlook, Ankush Kapoor, Founder & CEO of PharmNXT Biotech, discusses how India’s biotech ecosystem is redefining bioprocessing through Single-Use Technologies, Defined Tubing Routi

In an exclusive interview with Thiruamuthan, Assistant Editor of India Pharma Outlook, Jordan Kohlbeck, Head of Pharmaceuticals at IAG Cargo, discusses how India’s growing role as a global pharmaceutical exporter is driving transformation in the air

In an exclusive interview with Thiruamuthan, Assistant Editor at India Pharma Outlook, Ankit Gupta, President of ASPA, discusses how serialization and digital authentication are driving a paradigm shift in the pharmaceutical industry

Rehan Khan, Managing Director of MSD India, shares that India has more unicorn startups than billion-dollar drugs. Despite a huge patient pool with diabetes, hypertension, and cancer, the country has yet to deliver a homegrown therapy crossing $1 bil

The distribution was completely disregarded in this country. However, the time has come since distribution does not just imply taking the product and delivering to people in different locations.